Allspring Global Investments’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268K	Buy	11,746 +1,142	+11%	+$25.4K	﹤0.01%	1550
2025 Q4	$259K	Buy	10,604 +785	+8%	+$18.7K	﹤0.01%	1538
2025 Q3	$248K	Sell	9,819 -1,025	-9%	-$25.2K	﹤0.01%	1523
2025 Q2	$252K	Sell	10,844 -644	-6%	-$16.2K	﹤0.01%	1509
2025 Q1	$277K	Buy	+11,488	New	+$275K	﹤0.01%	1600
2024 Q4	–	Sell	-100,181	Closed	-$1.51M	–	2228
2024 Q3	$1.51M	Buy	100,181 +93,497	+1,399%	+$1.6M	﹤0.01%	1235
2024 Q2	$191K	Sell	6,684 -3,504	-34%	-$99.7K	﹤0.01%	1717
2024 Q1	$298K	Buy	10,188 +5,433	+114%	+$167K	﹤0.01%	1631
2023 Q4	$160K	Buy	4,755 +274	+6%	+$8.02K	﹤0.01%	1726
2023 Q3	$137K	Buy	4,481 +1,736	+63%	+$62.6K	﹤0.01%	1882
2023 Q2	$110K	Sell	2,745 -77,244	-97%	-$3.19M	﹤0.01%	2018
2023 Q1	$3.26M	Buy	79,989 +39,973	+100%	+$1.59M	0.01%	1110
2022 Q4	$1.55M	Sell	40,016 -186,748	-82%	-$9.09M	﹤0.01%	1316
2022 Q3	$12.1M	Sell	226,764 -11,863	-5%	-$660K	0.02%	708
2022 Q2	$13.9M	Buy	238,627 +148,043	+163%	+$9.7M	0.02%	688
2022 Q1	$6.91M	Sell	90,584 -4,407	-5%	-$294K	0.01%	1018
2021 Q4	$5.71M	Buy	+94,991	New	+$5.24M	0.01%	1129